[Treatment of endocrine ophthalmopathy].
D004700:Endocrine System Diseases / Q000150:complications*; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology / Q000532:radiotherapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007037:Hypothyroidism / Q000150:complications; D011879:Radiotherapy Dosage; D013959:Thyroid Diseases / Q000150:complications / Q000532:radiotherapy; D013974:Thyroxine / Q000627:therapeutic use; D014284:Triiodothyronine / Q000627:therapeutic use
D005938:Glucocorticoids; D006993:Hypnotics and Sedatives; D014284:Triiodothyronine; D013974:Thyroxine
Zur Behandlung der endokrinen Ophthalmopathie